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Randomized clinical trial to determine if changes in dentine tubule occlusion visualized by 
SEM of replica impressions correlate with pain scores 
 
Abstract. 
Purpose: To quantify dentine tubule occlusion and correlate this with pain reduction in vivo. 
Methods: This was a single-center, randomized two treatment, examiner-blind, parallel study. 20 
participants with confirmed dentine hypersensitivity (DH) were evaluated by Schiff Air Blast, VAS Air 
Blast and replica impression of the tooth surface to visualize tubule occlusion at baseline and 
following 4 week twice daily use of either an occluding toothpaste (8% strontium acetate, 1040 ppm 
fluoride) or a non-occluding toothpaste (1450ppm fluoride). Results: Both treatments increased 
tubule occlusion significantly from baseline to 4 weeks (p = 0.01) with significant decreases in pain 
score only seen with the occluding toothpaste (Schiff, p = 0.01; VAS, p = 0.01). Schiff pain score after 
4 weeks was markedly reduced following treatment with the occluding toothpaste as compared to the 
non-occluding toothpaste, (p = 0.05) with no significant differences between the pastes for occlusion 
score or patient reported VAS, although the scores favored the occluding toothpaste.  
Clinical Significance: Occlusion scores as obtained by replica impression techniques with SEM 
imaging correlate significantly with DH pain scores confirming proof of concept. With further 
refinement, this technique could be used to accurately quantify tubule occlusion in vivo and the 
associated pain reduction achieved by occluding toothpastes. 
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Introduction 
Dentine hypersensitivity (DH) is defined as pain arising from exposed dentine following a non-noxious 
stimulus which may be thermal, osmotic or tactile which cannot be attributed to any other dental 
defect or pathology.1 The condition is relatively common, with 42% of young adults in Europe 
reporting DH.2 DH is quick in onset, short-lived, but arresting with regards to pain intensity 3 and has 
been shown to affect quality of life.4 In a recent study 28.4% of sufferers stated that their DH pain was 
either important or very important to them,2 findings that emphasize the importance of understanding 
and developing treatments for this condition.  
The hydrodynamic theory is the most commonly accepted theory to explain DH and states that 
triggers of DH cause an outward flow of dentine tubule fluid which triggers a resultant pain response,5 
this suggests DH will only occur if dentine is exposed and patent to the pulp. This theory is supported 
by the finding that hypersensitive dentine contains more and larger patent dentine tubules than non-
sensitive dentine.6,7 Furthermore, the smear layer has been shown to occlude dentine tubules8 and it 
is often absent in hypersensitive dentine.7 The general acceptance of this theory as the mechanism 
underlying DH has led to the development of treatments designed to occlude dentine tubules. 
Toothpastes are an obvious choice for delivering agents designed to treat DH as they are easy to use 
at home and can occlude patent tubules. The agents most commonly included to treat the symptoms 
of DH are, strontium acetate, calcium sodium phosphosilicate (CSPS), stannous fluoride and arginine 
calcium carbonate.9 Confirmation that toothpastes containing these agents are able to occlude 
dentine tubules has been obtained both in vitro and in situ,10-12 and clinical studies in vivo have 
demonstrated that they are able to reduce DH pain.13-16 However, due to the difficulties of detecting 
tubule occlusion in a clinical environment there are a limited number of studies to date that have 
examined concurrent tubule occlusion and pain relief in vivo.  
The replica technique in which an impression of the tooth surface is made which can subsequently be 
viewed under a scanning electron microscope (SEM), first used to successfully visualize dentine 
tubules in vitro,17 can be used to investigate tubule occlusion in vivo, although few studies have used 
this methodology. It has been employed to investigate the tubule occlusion efficacies of professionally 
applied products and it was demonstrated that bonded resins that reduced DH pain also occluded 
dentine tubules.18 However, baseline sensitivity elicited by both stimuli was only mild in the majority of 
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study teeth and a significant reduction in pain was reported for the placebo immediately after 
treatment indicating the improvements observed could be simply due to the placebo effect. However, 
differences in pain response between placebo and test products were obtained after one month but 
no clinician assessed DH response was included in the study and tubule occlusion was not quantified, 
so a correlation between this and pain score was not possible.18 A study that examined the efficacy of 
professionally applied Gluma and a biomimetic agent for the treatment of DH using the replica 
technique similarly relied exclusively on patient reported pain. 19 It was demonstrated that both DH 
treatments reduced pain, however due to the mode of application it was not possible to blind patients 
to the treatment received and there was no negative control, thus it is difficult to discount the placebo 
effect at least for early study time points. While no difference in DH pain was observed between the 
agents tested at any time point, the anticipated levels of tubule occlusion were observed for only one 
agent, suggesting that reduction in hypersensitivity did not fully correlate with tubule occlusion.19 The 
failure to find good correlation between tubule occlusion could be in part due to the use of a 2 stage 
replica technique in which the negative replica initially taken was subsequently converted into a 
positive replica, as every translation of the tooth surface is likely to introduce inaccuracies. In the only 
other study to use this technique to assess the efficacy of professionally applied treatments in vivo, 
tubule occlusion following Nd:YAG laser treatment was observed using a one stage negative replica 
technique, but no pain measurements were made, thus it is not known to what degree the tubule 
occlusion observed correlated with a reduction in DH pain.20  
We also have previously conducted a pilot study using the negative replica technique and SEM 
imaging to investigate the relative efficacies of a strontium acetate DH and a fluoride control 
toothpaste to reduce DH and occlude dentine tubule in vivo.21 Although it was possible to visualise 
some dentine tubule occlusion we failed to demonstrate significant differences between the non-
occluding and occluding toothpaste or significantly correlate tubule occlusion with pain score. Indeed 
pain responses favoured the non-occluding toothpaste. Review of the SEM images showed residual 
impression material in the dentine tubules. This suggested that impression material had sheared off 
from the body of the impression during removal from the participants’ mouths and acted to occlude 
the tubules in both treatment groups indicating and observer effect whereby the act of taking the 
measurement altered the state of tubule occlusion. Subsequent investigation showed that at time 
points very close to the manufacturer’s recommended set time, a weaker strength of the impression 
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material than expected was observed. Thus the setting time indicated in the manufacturer’s 
instructions, while appropriate in normal dental treatment situations, appeared to be too short for the 
replica technique and indicated that the material needed to be handled differently when used for this 
research purpose. Toothpaste residue was also observed on impressions taken soon after treatment 
affecting the interpretation of images at early time points In addition, artefacts were observed on the 
tooth surface such as debris and indentations in the replica material that could have been the result of 
dentine tubule fluid exuded from the tubule during the impression procedure and these adversely 
affected occlusion scoring.  
The results of the above studies overall indicate that the replica18, 19 and negative replica 20,21 
impression technique may be valuable for confirming the association of tubule occlusion with 
decreased DH pain, providing definitive evidence in support of the hydrodynamic theory. However, 
they indicate that study methodologies need to be improved if a significant correlation between the 
degree of tubule occlusion observed and pain score is to be demonstrated. The primary aim of study 
was to confirm the relationship between dentine tubule occlusion and the reduction of DH. The 
dentine tubule occlusion and pain reduction capabilities of an occluding toothpaste (Sensodyne® 
Rapid Relief; 8% strontium acetate, 1040 ppm fluoride) as compared with a toothpaste with non-
occluding properties (Colgate® Cavity Protection; 1450ppm fluoride), were also evaluated.  
 
Materials and Methods: 
Trial design and selection of participants. 
This was a single center, randomized, two treatment parallel study, with treatment blinded to the pain 
assessor and impression examiner. NHS Research Ethics Committee (REC) approval was gained for 
the study and the study was carried out according to Good Clinical Practice guidelines as laid down 
by the Declaration of Helsinki and its later amendments in a UK dental school. Volunteers aged 18 or 
over that gave written informed consent were invited to a screening appointment where a medical 
history and oral soft tissue exam were undertaken, and the fulfilment of inclusion and exclusion 
criteria determined. Eligible participants were those with good general health, healthy gingivae and a 
minimum of one sensitive tooth without restoration and with exposed dentine at the cervical margin, 
demonstrating patent dentine tubules as determined at screening with an impression visualized under 
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the scanning electron microscope. Participants who were pregnant, had xerostomia, signs of 
gastroesophageal reflux disease, diabetes or an oral health condition that might interfere with study 
measures were excluded, as were those who were on medications that might interfere with their pain 
response. 
To confirm sensitivity, all teeth that showed signs of exposed dentine at the cervical margin were 
subjected to a 1 s air blast from a dental triple syringe at 60 ± 5 psi at 21°C ± 5°C directed 10mm 
perpendicular away from the exposed dentine of the test tooth. Sensitivity was scored by examiner 
sensitivity Schiff Score;22 0, participant does not respond to stimulus; 1, participant responds to 
stimulus but does not request discontinuation of stimulus; 2, participant responds to stimulus and 
requests discontinuation or moves from stimulus; 3, participant responds to stimulus, considers 
stimulus to be painful and requests discontinuation of stimulus. Up to a maximum of 4 teeth with 
Schiff score 2 or 3 were then assessed for dentine tubule patency, in the event that more than 4 teeth 
gave Schiff scores of 2 or 3, those which were most sensitive were selected. To confirm dentine 
tubule patency of these teeth, silicone impressions of the cervical margin of the tooth with exposed 
dentine were taken using Aquasil Ultra XLV® (Dentsply Sirona, Weybridge, Surrey, UK) and 
immediately examined under SEM for tubule patency. Although only one tooth per participant was 
selected for study treatment, impressions of 4 teeth were taken where possible as dentine is 
susceptible to damage, and this enabled selection of the tooth with the greatest patency for the study. 
Impressions (negative replicas of the natural tooth) were scored for tubule patency by reference to 
existing images demonstrating varying degrees of dentine tubule occlusion and their associated 
tubule occlusion score. A 5 point scoring system was used in which dentine tubules that were fully 
occluded scored 1, dentine tubules that were mostly occluded scored 2, dentine tubules that were 
almost equally occluded/unoccluded scored 3, dentine tubules that were mostly unoccluded scored 4 
and dentine tubules that were unoccluded scored 5. Only teeth with Examiner Schiff score of 2 or 3 
and occlusion score of 4 or more were acceptable for study inclusion. Only one tooth per participant 
was selected for the treatment phase, and an area of patent tubules identified for further examination 
following treatment.  A light microscope image of the area identified on the impression was taken 
using the gingival margin of the impression replica as a reference in conjunction with the surface 
landmarks on the impression of the natural tooth, to allow future imaging post treatment to be carried 
out in the same area. 
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Participants with an eligible tooth and who satisfied all other eligibility requirements were enrolled onto 
the study and given a standard toothbrush and washout toothpaste (Colgate® Cavity Protection, 
Colgate, Guildford, Surrey, UK) for use twice daily for a minimum of 24 hours before the treatment 
visit. Only one tooth per participant was selected for study procedures.  
 
Study treatments 
Following the screening visit, eligible participants returned to the study site for the start of the 
treatment period within 14 days of the screening visit. Participants were asked to refrain from eating 
and drinking with the exception of water in the hour before their visit, and to brush their teeth with the 
washout toothpaste between 1 and 3 hours prior to their study appointment. Participants were given a 
visual analogue score (VAS) training exercise to complete and their general ongoing study eligibility 
was confirmed by an oral soft tissue exam. At this visit the selected tooth was also re-assessed for 
sensitivity and tubule occlusion using examiner Schiff and SEM tubule occlusion score, only 
participants whose selected tooth continued to fill the eligibility criteria of Schiff score >2 and tubule 
occlusion score >4 were advanced to the treatment phase. In addition, prior to impressions being 
taken to assess tubule occlusion, participants were asked to rate their dentine hypersensitivity using 
VAS. Participants for whom ongoing eligibility was confirmed were randomized to either Sensodyne® 
Rapid Relief (occluding; GSK, Brentford, Essex, UK), or Colgate® Cavity Protection (non-occluding), 
using a pre-determined randomization schedule, participants being randomized by study staff in the 
order in which they were confirmed eligible to continue in the study. Participants were provided with 
their study toothpaste, a new toothbrush and instructions on product use at home. The decision to use 
the same positive control (Sensodyne® Rapid Relief) in this study as the previous study was made as 
there is good evidence for its tubule occluding ability11, and its ability to provide relief from DH 14, 23 
and it was felt that the poor result obtained as compared to the control toothpaste in the pilot study 
was soley due to technical issues encountered with the replica impressions. A different standard 
fluoride control toothpaste was selected at random. 
During the treatment phase of the study participants brushed with the study product twice daily for two 
timed minutes for 4 weeks, after which they returned to the study site for their final visit. The use of 
other oral health care products during this time was prohibited, with the exception of occasional use of 
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floss to remove trapped dietary debris. Participants were asked to refrain from eating and drinking 
with the exception of water in the hour before their final visit, and to brush their teeth with their study 
toothpaste between 1 and 3 hours prior to their study appointment. Participants were given VAS 
refresher training, their selected tooth was assessed for sensitivity by examiner Schiff and VAS, and a 
final silicone impression was taken to determine dentine tubule occlusion.  
Taking impressions 
Throughout the study replica impressions were taken immediately after sensitivity had been scored. 
Prior to taking an impression the surface of the selected tooth was wiped gently to remove any oral 
debris and dried in the air without the use of an air blast, prior to the silicone application, the silicone 
impression material dispensed from a cartridge was applied directly to the sensitive area of the tooth 
and allowed to set for 6 minutes (2 minutes longer than the manufacturers guidance for normal clinical 
use). When set, the silicone was carefully peeled from the tooth, with no pressure applied during the 
set of the material. One replica impression per selected tooth was taken at each study time point. 
Prior to SEM analysis, replica impressions were disinfected in 1000 ppm available chlorine solution 
for 10 min, then rinsed well under running water. The replica impression of the sensitive area was 
imaged directly using SEM at 2000X magnification using a Phenom bench top SEM (Phenom-World 
BV, Eindhoven, The Netherlands) without the need to prepare a positive replica which by virtue of 
adding a second impression step might introduce additional error. The SEM imaging and classification 
was carried out by a single appropriately trained examiner blind to the treatment that had been 
applied to the tooth from which the replica impression had been obtained. The examiner was trained 
to recognize dentine tubule occlusion as visualized with the replica impression technique across the 
range of scores (1-5), with results validated against standardized image scores, a weighted Kappa 
coefficient (κ) using the Fleiss-Cohen method of weighting to assess examiner reliability. The 
reliability was deemed excellent (κ > 0.75). 
 
Statistical methods 
This was a preliminary study to determine if replica impressions visualized by SEM could detect 
changes in tubule patency in sensitive teeth treated with an occluding or non-occluding toothpaste. The 
sample size was not based upon statistically powered sample size calculations to detect clinically 
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relevant differences between treatment groups, but was considered adequate to provide useful 
information for the design of future studies. It was anticipated that if 20 participants were randomized 
this should ensure that at least 15 participants completed the study. 
Outcome measures were dentine tubule occlusion, evaporative air Schiff Scores and patient reported 
VAS score after 4 weeks of treatment, and change from baseline at 4 weeks from treatment. 
Dentine tubule occlusion and evaporative air Schiff Scores were analyzed using non-parametric 
methods. A Wilcoxon rank sum test was performed to test for differences between treatments and 
Wilcoxon signed rank test was performed to look at changes from baseline visit within treatment. The 
relationship between Schiff score, VAS and the dentine tubule occlusion score was assessed using the 
Pearson’s correlation coefficient. The statistical analysis was carried out using the SPSS version 21. 
Results 
A total of 20 participants were eligible for the study and were randomized, 10 receiving each treatment, 
all participants randomized to study products completed the study between August and December 2014. 
There were 3 male and 17 female participants, with a mean age of 42.1 years. No protocol deviations 
or adverse events were recorded during the study thus the intention to treat and per protocol populations 
were the same.  
To determine whether tubule occlusion correlated with dentine hypersensitivity pain scores, all the 
baseline and 4 week data from each treatment was considered together. Evaporative air Schiff pain 
scores correlated significantly with patient reported VAS scores, p = 0.015. Occlusion scores also 
correlated significantly with both pain scores, p = 0.031 and p = 0.045 for examiner reported Schiff and 
patient reported VAS respectively.  
Analysis within treatments demonstrated that for both treatments tubule occlusion increased 
significantly from baseline to 4 weeks (SRR, p = 0.01; CCP, p = 0.01; table 1). However, significant 
decreases in pain score were only seen with the occluding toothpaste SRR (Schiff, p = 0.01; VAS, p = 
0.01). 
Comparing treatments at each time point, it was confirmed that there were no significant differences 
between the groups randomized to SRR or CCP prior to treatment for any measure tested. After 4 
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weeks treatment pain score as assessed by examiner Schiff was significantly reduced following 
treatment with SRR as compared to CCP, (p = 0.05; table 2). There were no significant differences 
between toothpastes for occlusion score or patient reported VAS although the scores favored the 
occluding toothpaste. 
 
Discussion 
This study aimed to further develop the replica impression technique and confirm that tubule 
occlusion captured by the technique in vivo correlated with DH pain. Further the study sought to 
determine whether the technique was able to differentiate between the degrees of tubule occlusion 
achieved following treatment with an occluding or non-occluding toothpaste.  
The methodology of the present study was based on that of our pilot study21 but modified to address 
the technical issues encountered as follows: prior to impression taking, following a gentle wipe the 
tooth was dried by isolating and leaving to dry naturally in the environment, as opposed to being dried 
with an air blast, to prevent increased outward dentine tubule fluid flow; the impression material was 
allowed to set for 6 min as compared 4min and handled with extreme care to avoid material shearing 
off within tubules; and no impressions were taken immediately after use of toothpaste to avoid issues 
associated with toothpaste debris. The control toothpaste was also changed in ensure the abrasive 
was not contributing to the reduction in DH by tubule occlusion. 
The study successfully demonstrated that dentine tubule occlusion scores obtained from replica 
impressions taken using Aquasil Ultra XLV impression material significantly correlated with DH pain 
scores in vivo. This finding provides direct evidence to support the hydrodynamic theory of 
Brannstrom.5  
The findings are broadly in agreement with one  replica study that demonstrated that professionally 
applied dentine desensitizing agents reduced DH pain and occluded dentine tubules,18 However, this 
study did not quantify the tubule occlusion observed, so a quantitative correlation with pain score to 
provide direct evidence for the hydrodynamic theory was not possible. The findings are also 
supported by a study in which tubule occlusion by the smear layer was associated with non-sensitive 
dentine,7 but the degree of DH pain was not scored, so whether occlusion correlated significantly with 
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DH pain could not be determined. By contrast Guentsch et al19 demonstrated that while both 
professional treatments tested caused a similar reduction in pain scores, for one of the treatments 
tubule occlusion was only partial.1  Similarly, in a previous study, a significant correlation between 
tubule occlusion and pain was not observed, although the correlation was positive. 21 
The present study demonstrated that DH pain scores in the SRR (occluding) group decreased 
significantly by 4 weeks. By contrast, and as predicted, the control (non-occluding) toothpaste did not 
reduce pain scores significantly over this period. The demonstration that SRR (occluding) reduced DH 
pain is in agreement with previous clinical studies which have demonstrated strontium acetate 
containing toothpastes reduce pain at time points from 3 days to 8 weeks.14, 23 
By contrast to the findings for pain reduction, in the present study it was demonstrated that both 
toothpastes resulted in significant tubule occlusion after 4 weeks, the results slightly favoring the 
occluding toothpaste. The data for SRR, the occluding toothpaste is as expected, as it has been 
demonstrated to occlude dentine tubules in vitro and in situ.24 But in contrast to the current study, 
previous studies have demonstrated that strontium acetate occluding toothpastes are able to occlude 
dentine tubules better than non-occluding control toothpastes.12, 25 It is possible that in the present 
study impression material was retained became lodged in open dentine tubules, and snapped off 
when the impression was removed from the participant’s mouth resulting in ‘false occlusion’. If this 
was the case it would be more likely to occur in participants in the non-occluding group who would be 
anticipated to have more patent dentine tubules. However, in contrast to our previous study21 obvious 
signs that impression material had lodged in dentine tubules were missing from the SEM images, 
likely a result of the additional setting time and careful handling of the material, however it is possible 
that the impression material snapped off a few microns into the tubule orifice.  
Other artefacts that interfered with scoring were also present on some replica impressions. While the 
tooth surface was carefully wiped prior to the impression to remove debris, inevitably a small amount 
of debris was observed. In addition, patterns in the replica impression that could have been caused by 
outward dentine fluid movement from unoccluded tubules were seen on some impressions. On a 
replica impression, outward fluid movement from an unoccluded dentine tubule leaves an indentation, 
as opposed to a finger of impression material that is seen when the material penetrates unoccluded 
tubules, thus this also can result in ‘false positives’. This artefact, therefore could also be responsible 
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for the higher than anticipated occlusion scores obtained in the control toothpaste, which 
consequently did not fully reflect the pain scores. These scores obtained with this toothpaste  not 
being significantly reduced in the control group after 4 weeks for either assessment measure.  
Another possibility to reconcile the occlusion and pain scores for the control paste is whether there 
was a placebo effect with respect to the pain score, as substantial placebo effects have been 
previously reported for dentine hypersensitivity studies30. However, the duration of the present study 
was relatively long, and both toothpastes were used twice a day in line with normal oral healthcare 
regimes so the likelihood of participants behaving differently because they were on a clinical trial was 
reduced. Further both patient reported VAS and examiner assessed Schiff scores favoured the 
occluding toothpaste, with the improvements in VAS for the occluding toothpaste being much greater 
than those observed for the control toothpaste, even though the difference was only significant for 
Schiff. It is recognised that pain measurements are subjective31 with pain being hard to quantify32. 
However, the dental examiner was experienced in judging patient response to pain, when recording 
Schiff score, and to what degree participants are able to modify their response to a trigger of DH is 
not clear. While VAS scores are more readily by the placebo effect, it is important to record patient 
reported pain. VAS has been shown to be work well oral surgery post operative pain,33 and recently in 
a DH study has been shown to distinguish between cold and warm water stimuli similar to a labelled 
magnitude scale and was preferred by some of the study participants,34 supporting its use in DH 
studies. 
In the current study there were no significant differences between the toothpastes after 4 weeks of 
treatment for occlusion score or VAS, however the data favored the occluding toothpaste, and there 
was a significant difference between toothpastes as scored by Schiff (p=0.05). Other clinical studies 
have demonstrated that strontium acetate containing toothpastes provide significantly better pain 
relief than fluoride control toothpastes at least in the short term.26 As this was an exploratory study it 
was not powered to detect differences between treatments, but to inform future studies.  We were, 
however, able to demonstrate significant improvements in pain score for SRR but not CCP. Perhaps 
with more participants, differences between the two products after treatment would become more 
apparent, although two other studies have also demonstrated no differences in the pain relief 
achieved following treatment of DH with SRR as compared to a fluoride control after 7 days and 2, 4, 
and 8 weeks.27, 28 
 12 
 
Taken together the results of this study confirm that occlusion scores as obtained by replica 
impression techniques with SEM imaging correlate significantly with DH pain score, but the technique 
still needs refining to detect significant differences in tubule occlusion between toothpastes in vivo. 
The technique and impression material used in the present study has been successfully used to 
follow the course of early enamel erosion and recovery,29 but improvements in impression materials 
shear properties are required before replication of dentine tubule status can be achieved to an 
accuracy that allows for clear distinction between occluding and non-occluding toothpastes. 
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Table 1: Within treatment analysis of occlusion and sensitivity scores from baseline to 4 weeks 
 Baseline Visit 4 Weeks (Final Visit) p value 
Mean Standard 
Deviation 
Mean Standard 
Deviation 
Sensodyne
® Rapid 
Relief 
Occlusion 4.4 0.52 2.5 0.97 0.01 
Schiff 2.0 1.15 0.5 0.71 0.05 
VAS 66.9 19.05 40.4 25.44 0.01 
Colgate® 
Cavity 
Protection 
Occlusion 4 0.00 2.7 0.95 0.01 
Schiff 1.6 0.84 1.5 1.08 0.71 
VAS 47.1 24.41 49.7 28.98 0.92 
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Table 2. Differences in occlusion, examiner Schiff and self-reported VAS score between SRR 
and CCP at all study time points 
 Sensodyne® Rapid Relief Colgate® Cavity Protection Sensodyne 
vs Colgate 
(p value) 
Number Mean Standard 
Deviation 
Number Mean Standard 
Deviation 
Screening Occlusion 10 4.8 0.42 10 4.5 0.53 0.28 
Schiff 10 2.1 0.57 10 2 0.00 0.74 
Baseline 
Visit 
Occlusion 10 4.4 0.52 10 4.0 0.00 0.14 
Schiff 10 2.0 1.15 10 1.6 0.84 0.25 
VAS 10 66.9 19.05 10 47.1 24.41 0.11 
4 Weeks 
(Final 
Visit) 
Occlusion 10 2.5 0.97 10 2.7 0.95 0.63 
Schiff 10 0.5 0.71 10 1.5 1.08 0.05 
VAS 10 40.4 25.44 10 49.7 28.98 0.48 
 
 
